Back to Search
STANLEY PILLEMER, MD
MD
Internal Medicine Physician
NPI: 1306088661Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
D0031644(MD)
Research & Publications (20)
Outcome measures for Sjögren's syndrome, April 10-11, 2003, Bethesda, Maryland, USA.
PMID 15630740·J Rheumatol·2005
6-review
Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, Minnesota.
PMID 11393497·Mayo Clin Proc·2001
8-other
Phase-1 study of siplizumab in the treatment of pediatric patients with at least grade II newly diagnosed acute graft-versus-host disease.
PMID 19671093·Pediatr Transplant·2010
3-trial
Lack of efficacy of etanercept in Sjögren syndrome correlates with failed suppression of tumour necrosis factor alpha and systemic immune activation.
PMID 18198195·Ann Rheum Dis·2008
2-rct
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I.
PMID 18163481·Arthritis Rheum·2008
8-other
Augmented interferon-alpha pathway activation in patients with Sjögren's syndrome treated with etanercept.
PMID 18050196·Arthritis Rheum·2007
2-rct
Lymphoma and other malignancies in primary Sjögren's syndrome.
PMID 16699050·Ann Rheum Dis·2006
8-other
Distinct recognition of antibodies to centromere proteins in primary Sjogren's syndrome compared with limited scleroderma.
PMID 16414973·Ann Rheum Dis·2006
8-other
Immunological consequences of thalidomide treatment in Sjögren's syndrome.
PMID 16344495·Ann Rheum Dis·2006
2-rct
B cell MALT lymphoma diagnosed by labial minor salivary gland biopsy in patients screened for Sjögren's syndrome.
PMID 15708896·Ann Rheum Dis·2005
5-case
Central nervous system disease in primary Sjogrens syndrome: the role of magnetic resonance imaging.
PMID 15609267·Semin Arthritis Rheum·2004
6-review
Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjögren's syndrome.
PMID 15334433·Arthritis Rheum·2004
3-trial
Etanercept in Sjögren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial.
PMID 15248223·Arthritis Rheum·2004
3-trial
Prominent adverse effects of thalidomide in primary Sjögren's syndrome.
PMID 15188341·Arthritis Rheum·2004
3-trial
Centromere protein C is a target of autoantibodies in Sjögren's syndrome and is uniformly associated with antibodies to Ro and La.
PMID 15170924·J Rheumatol·2004
8-other
The stable nitroxide tempol facilitates salivary gland protection during head and neck irradiation in a mouse model.
PMID 15014035·Clin Cancer Res·2004
7-preclinical
Local adeno-associated virus-mediated interleukin 10 gene transfer has disease-modifying effects in a murine model of Sjögren's syndrome.
PMID 14633403·Hum Gene Ther·2003
7-preclinical
Use of localised gene transfer to develop new treatment strategies for the salivary component of Sjögren's syndrome.
PMID 14583564·Ann Rheum Dis·2003
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7408 COASTAL HWY
OCEAN CITY, MD 21842 - Phone
- (410) 524-0075
Quick Facts
- NPI
- 1306088661
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile